Thrombolytic therapy for stroke: The new paradigm

Hospital Practice

Volumn 32, Issue 11, 1997, Pages 57-73

  Levine, Steven R ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; APTIGANEL; STREPTOKINASE;

BLOOD CLOT LYSIS; BRAIN INFARCTION; FIBRINOLYTIC THERAPY; HUMAN; NEUROPROTECTION; PATIENT SELECTION; REVIEW; STROKE; THROMBOSIS; TREATMENT OUTCOME;

EID: 0030732095     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1997.11443597     Document Type: Review

References (14)

1. Adams HP et al: Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 94:1167, 1996
2. Alberts MJ et al: Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 23:352, 1992
3. Barsan WG et al: Time of hospital presentation in patients with acute stroke. Arch Intern Med 153:2558, 1993
4. Barsan WG et al: Urgent therapy for acute stroke. Stroke 25:2132, 1994
5. Camarata PJ, Heros RC, Latchow RE: "Brain attack": The rationale for treating stroke as a medical emergency. Neurosurgery 34:144, 1994
6. Donnan GA et al: Trials of streptokinase in severe acute ischaemic stroke. Lancet 345:578, 1995
7. Hacke W et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017, 1995
8. Lutsep HL et al: Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41:574, 1997
9. Multicenter Acute Stroke Trial-Europe Study Group: Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 335:145, 1996
10. Multicentre Acute Stroke Trial-Italy (MAST-1) Group: Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346:1509, 1995
11. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group: A systems approach to immediate evaluation and management of hyperacute stroke: Experience at eight centers and implications for community practice and patient care. Stroke 28:1530, 1997
12. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581, 1995
13. Williams LS et al: Stroke patients' knowledge of stroke: Influence on time to presentation. Stroke 28:912, 1997
14. Zivin JA et al: Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289, 1985